Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.
about
The Potential Cost-Effectiveness of HIV Vaccines: A Systematic ReviewRevisiting annual screening for latent tuberculosis infection in healthcare workers: a cost-effectiveness analysis.Cost-effectiveness analysis of the diarrhea alleviation through zinc and oral rehydration therapy (DAZT) program in rural Gujarat India: an application of the net-benefit regression framework.Economic evaluation of a population-based osteoporosis intervention for outpatients with non-traumatic non-hip fractures: the "Catch a Break" 1i [type C] FLS.A Systematic Review of Cost-Effectiveness Studies Reporting Cost-per-DALY Averted.Weight-loss and exercise for communities with arthritis in North Carolina (we-can): design and rationale of a pragmatic, assessor-blinded, randomized controlled trialUpdated Priorities Among Effective Clinical Preventive Services.Association between work time loss and quality of life in patients with Herpes Zoster: a pooled analysis of the MASTER studies.The cost of a patient activation intervention for achieving successful outcomes: results from the PAADRN randomized controlled trial.Monetary conversion factors for economic evaluations of substance use disorders.Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control.Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease.Costs and expected gain in lifetime health from intensive care versus general ward care of 30,712 individual patients: a distribution-weighted cost-effectiveness analysis.Cost effectiveness of a practice-based intervention to improve vaccination rates in adults less than 65-years-old.Adjuvant HPV vaccination for anal cancer prevention in HIV-positive men who have sex with men: The time is now.Cost-effectiveness of preimplantation genetic screening for women older than 37 undergoing in vitro fertilization.Cost-effectiveness of left ventricular assist devices for patients with end-stage heart failure: analysis of the French hospital discharge database.Cost-Effectiveness of Radiation and Chemotherapy for High-Risk Low-Grade Glioma.Cost-effectiveness of blinatumomab versus salvage chemotherapy in relapsed or refractory Philadelphia-chromosome-negative B-precursor acute lymphoblastic leukemia from a US payer perspective.Cost Effectiveness of Pembrolizumab vs. Standard-of-Care Chemotherapy as First-Line Treatment for Metastatic NSCLC that Expresses High Levels of PD-L1 in the United States.Does cost-effectiveness of influenza vaccine choice vary across the U.S.? An agent-based modeling study."Naming and Framing": The Impact of Labeling on Health State Values for Multiple Sclerosis.A Comparison of the Validity and Responsiveness of the EQ-5D-5L and SF-6D for Measuring Health Spillovers: A Study of the Family Impact of Meningitis.The Monthly Cycle of Hypoglycemia: An Observational Claims-based Study of Emergency Room Visits, Hospital Admissions, and Costs in a Commercially Insured Population.Prevention of renal failure in Chinese patients with newly diagnosed type 2 diabetes: A cost-effectiveness analysis.Bayesian Methods for Calibrating Health Policy Models: A Tutorial.Evaluating Frameworks That Provide Value Measures for Health Care Interventions.Population-based cost-offset analyses for disorder-specific treatment of anorexia nervosa and bulimia nervosa in Germany.Saving lives efficiently across sectors: the need for a Congressional cost-effectiveness committee.School-Based Dental Sealant Programs Prevent Cavities And Are Cost-Effective.Health-Related Resource-Use Measurement Instruments for Intersectoral Costs and Benefits in the Education and Criminal Justice SectorsThe value of point-of-care CD4+ and laboratory viral load in tailoring antiretroviral therapy monitoring strategies to resource limitations.Decision-Making in Critical Limb Ischemia: A Markov Simulation.Definition of a Geriatric Depression Scale cutoff based upon quality of life: a population-based study.Using Genomic Information to Guide Ibrutinib Treatment Decisions in Chronic Lymphocytic Leukaemia: A Cost-Effectiveness AnalysisThe search for relevant outcome measures for cost-utility analysis of systemic family interventions in adolescents with substance use disorder and delinquent behavior: a systematic literature review.Management of precancerous anal intraepithelial lesions in human immunodeficiency virus-positive men who have sex with men: Clinical effectiveness and cost-effectiveness.Predicting carer health effects for use in economic evaluation.Benefits, Challenges and Potential Strategies of Open Source Health Economic ModelsCost effectiveness and return on investment of a scalable community weight loss intervention.
P2860
Q28973596-364AE326-2E0C-481C-ADFA-0A0ED12AE6B8Q33702764-9AF310F3-5C5C-4401-8AB9-3952FFABA834Q33781562-02592922-D67D-4A7B-8C2B-3D1F3894CEF4Q33841955-A9C2D68D-789B-49A1-A3C7-C5B827DBF261Q36231593-47658428-D319-4581-B61A-C378474C6285Q36287764-1D51874B-4AA6-4FEE-BA3C-6AB4C0419348Q37567485-CEECF242-4A2A-49DE-8957-C024CAF429FAQ37591630-551DB9C3-84BE-41BA-9402-C9C924D66D03Q38375490-6C4763C2-30D4-4914-9C45-EAC4D6D6CFC1Q38605382-1721BF7E-A345-43BE-A04F-B825EA2C06FAQ38611655-95DE2518-2FB0-428E-913F-31B8AEF1804BQ38612448-BC0344EB-4F9D-4627-8B21-109EFEF53978Q38613643-432E6E55-865C-4481-B0BD-ABF38C566946Q38614227-B9CF1F58-7CE1-4D03-8337-CE741B47022EQ38625214-702A4ABB-647B-4FE7-8B0E-1826D9ACA7B5Q38658432-8D867659-D72E-4B1F-9350-35B7E77132AFQ38662720-12F82CF1-CC59-4AB7-85AA-BF2498DE705CQ38699783-E84BA73F-6F7B-4476-930A-1443150F3E84Q38717851-80FD38ED-43ED-410F-8F28-8B65A35F0ECAQ38722972-203C216F-B58C-4B46-B806-0FCD7DD46602Q38729177-4895AA28-0474-46C7-BB8E-DA1045E43C2DQ38772696-8F7484CA-BE1C-4C52-A097-2FDA780EB079Q38774305-083796B3-7068-4F95-8610-66BCD5459EB8Q38798258-0462FCC0-2338-4C1C-8D0B-957E1440896CQ38906326-0C1BCB3F-8EA0-4D27-BEBC-E90CA74C2ED8Q38936428-85FA4EF2-E3D7-48C4-B9D4-C1FF9350EABCQ38942315-E572B3EF-5E02-45FD-8041-A2B164BEBC71Q38984071-B69EFA7C-119F-4A63-8356-AD6E8C214B75Q39005565-12B583C0-8331-41FC-9CD3-8858E5213CF2Q39128432-F97D9B31-52AE-438D-A21D-A3BB11FF7C93Q39361444-17A03C35-C113-4665-8466-000B93F626C4Q40041518-C1EBB10B-C08C-487A-9703-ACBFF614D60BQ40121915-837633E0-8535-4483-8A52-C621530FBB1CQ40261095-E93D1868-9BDA-492F-93BD-97754CD385A6Q41310328-AEE5814F-F497-447D-94D3-41DAA753273AQ41713802-C2355D77-7227-4906-89C5-B9EF8477F010Q41929949-AFB29023-8C15-4B8F-A833-D0222A67EECBQ41982214-313D790A-E67B-4AF6-88B5-52F98708C9FBQ42334579-B08B6A5D-475D-4F7C-8827-16A4128229FBQ45069487-984DC81F-6FB1-42C8-8896-29D1899EFCF4
P2860
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Recommendations for Conduct, M ...... veness in Health and Medicine.
@en
type
label
Recommendations for Conduct, M ...... veness in Health and Medicine.
@en
prefLabel
Recommendations for Conduct, M ...... veness in Health and Medicine.
@en
P2093
P356
P1476
Recommendations for Conduct, M ...... veness in Health and Medicine.
@en
P2093
Anirban Basu
Dan W Brock
David Feeny
David O Meltzer
Douglas K Owens
Gillian D Sanders
Joanna E Siegel
Karen M Kuntz
Lisa A Prosser
Louise B Russell
P304
P356
10.1001/JAMA.2016.12195
P407
P577
2016-09-01T00:00:00Z